{
    "title": "AstraZeneca gets share lift on ground-breaking lung-cancer drug trials",
    "url": "https://www.dailymail.co.uk/money/markets/article-4500998/AstraZeneca-gets-share-lift-lung-cancer-drug-trials.html",
    "date": "2017-05-12",
    "keywords": [
        "cancer",
        "drug",
        "lung",
        "firm",
        "success",
        "imfinzi",
        "astrazeneca",
        "leapt",
        "risk",
        "death",
        "cancerthe",
        "bodys",
        "immune",
        "system",
        "aldis",
        "boss",
        "share",
        "market",
        "soriot",
        "pay",
        "ftse",
        "cent",
        "progression",
        "stage",
        "part",
        "studyimfinzi",
        "trial",
        "type",
        "protein",
        "magic",
        "town",
        "size",
        "watford",
        "entertainment",
        "fall",
        "tv",
        "production",
        "company",
        "probe",
        "bank",
        "staff",
        "lloyds",
        "city",
        "star",
        "article",
        "class",
        "wave",
        "development",
        "number",
        "sectorastrazeneca",
        "light",
        "bladder",
        "opportunity",
        "tremelimumab",
        "immunocology",
        "compound",
        "kind",
        "combination",
        "treatment",
        "yearthe",
        "leader",
        "diseasethe",
        "win",
        "shareholder",
        "revolt",
        "package",
        "meeting",
        "london",
        "loss",
        "patent",
        "cholesterol",
        "medicine",
        "crestorbut",
        "growth"
    ],
    "category": [
        "money",
        "markets"
    ]
}